Getting GLPs Without Insurance: Your Real Options, Real Prices, and Where to Buy

Start with your own doctor

The safest way to take tirzepatide is under a physician who knows your history, your medications, and your labs. I say that first because it matters most.

This is a powerful medicine. It changes how your stomach empties, how your pancreas responds to food, and how much you eat. It can lower blood pressure and blood sugar enough that your other prescriptions need adjusting. A doctor who knows you catches those things. A website questionnaire does not.

I also know the reality. Insurance often refuses to pay, and some people have no coverage or no primary doctor at all. If that is you, there are legitimate ways to get this medicine. This guide lays them out in order, from the option I trust most to the one I would use only as a last resort. Whatever path you choose, tell your doctor you are taking it, and bring this guide to your next visit.

The 60-second version

• See your own doctor first. Ask about Zepbound, the FDA-approved form of tirzepatide for weight management.

• Check coverage before paying cash. With commercial insurance that covers it, the manufacturer’s savings card can bring the cost to as little as $25 a month.

• On Medicare? A new program covers the Zepbound KwikPen for no more than $50 a month if you meet its criteria.

• Paying cash? The manufacturer sells genuine Zepbound directly for $299 to $449 a month. Any prescriber can send the prescription.

• No doctor? Use a telehealth service that prescribes the FDA-approved product, not a copy.

• Compounded tirzepatide is the last resort. It is not FDA-approved, and the FDA has warned dozens of online sellers this year about misleading claims.

• “Best provider” lists are advertisements. The sites that publish them are typically paid by the companies they rank.

Your real options and real prices

Work down this list and stop at the first one that fits. Prices are for a 28-day supply, checked October 2026, and the manufacturer can change them at any time.

Option 1. Use your insurance: as little as $25 a month

Who it fits: people with employer or private insurance that covers Zepbound.

How to do it:

1. Check your coverage in a few minutes with the manufacturer’s coverage checker.

2. Ask your doctor to prescribe Zepbound and submit a prior authorization. If it is denied, ask the office to appeal. Many denials are reversed.

3. Get the Zepbound savings card and show it at your pharmacy. Savings card help line: 1-866-923-1953.

Know this: the card is not available to anyone on Medicare, Medicaid, TRICARE, or VA coverage, and it expires December 31, 2026.

Option 2. Medicare: no more than $50 a month

Who it fits: Medicare Part D members who meet the program’s criteria.

How to do it:

1. Ask your doctor whether you qualify. In general you need a BMI of 35 or higher, a BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease, or a BMI of 27 or higher with certain conditions such as prediabetes or a prior heart attack or stroke.

2. Your doctor prescribes the Zepbound KwikPen and submits the Medicare GLP-1 Bridge authorization.

3. Fill it at your pharmacy. Read the details at Medicare.gov or call 1-800-MEDICARE (1-800-633-4227).

Know this: the program runs from July 1, 2026 through December 31, 2027. It covers the KwikPen only, not the single-dose pen or vials. Extra Help cannot be applied to the $50 copay.

Option 3. Buy it direct from the manufacturer: $299 to $449 a month

Who it fits: people with no coverage, or coverage that excludes Zepbound. This is the option most people do not know about.

How to do it:

1. Ask any licensed prescriber to send an electronic prescription for Zepbound (KwikPen or single-dose vials) to the LillyDirect self-pay pharmacy.

2. Go to LillyDirect, create an account, and pay online. It ships to your home.

3. Reorder on time. At 7.5 mg and above, you keep the lower price only by refilling within 45 days.

What you pay for 28 days:

• 2.5 mg (starting dose): $299

• 5 mg: $399

• 7.5 mg, 10 mg, 12.5 mg, and 15 mg: $449 with an on-time refill. Without it, $499 at 7.5 mg and $699 at 10 mg and above

Know this: vials mean drawing up your own dose with a syringe, so ask for a teaching visit. Self-pay purchases cannot be billed to insurance. Health savings and flexible spending accounts can often be used; check with your plan.

Option 4. No doctor? Telehealth that prescribes genuine Zepbound

Who it fits: people with no doctor or no timely appointment.

How to do it:

1. Start at LillyDirect, which lists independent telehealth services, or use its in-person care finder to locate a doctor near you.

2. Complete the visit honestly and in full. Have your medication list and any recent labs ready.

3. Ask that the prescription be for FDA-approved Zepbound and sent to LillyDirect or your own pharmacy.

Know this: you pay the same drug price as Option 3, plus the service’s own visit or membership fee. Ask for the total before you sign up.

Option 5. A different FDA-approved medicine: from $149 a month

Who it fits: people for whom cost or needles are the barrier. These are different drugs with somewhat less average weight loss than tirzepatide, so a prescriber should decide whether one suits you.

• Foundayo (orforglipron), a daily pill from Eli Lilly. Self-pay starts at $149 a month for the lowest dose, with higher doses up to $349. Order through LillyDirect; product details at foundayo.lilly.com.

• Wegovy pill (oral semaglutide), a daily pill from Novo Nordisk. Self-pay is $149 a month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg, through NovoCare Pharmacy with home delivery.

• Wegovy injection, once weekly. Self-pay is $349 a month at most doses through NovoCare Pharmacy.

Option 6. Compounded tirzepatide: the last resort

A compounded drug is mixed by a pharmacy from raw ingredient. It is not a generic, and it is not FDA-approved. The FDA does not check it for safety, strength, or quality before it reaches you. The agency’s position is that compounded drugs are for patients whose needs cannot be met by an approved drug. The shortage that once justified mass compounding has ended, and the FDA is now moving to restrict it further. With genuine Zepbound at $299 to $449, the savings rarely justify the uncertainty.

If you still choose this route, read the FDA’s page on buying medicine online safely, confirm the pharmacy is licensed in your state, and use the ten questions below.

Where to buy online

The first place to look is the manufacturer’s own pharmacy, LillyDirect. It sells genuine Zepbound at the self-pay prices above, ships to your home, and can connect you with a telehealth prescriber if you have none.

Beyond that, you will see “best tirzepatide provider” rankings all over the internet.

A ranking with scores like 9.8 and “Exceptional” is an advertisement, not a medical review. Comparison sites are typically paid when you click through and sign up, and the order often reflects that. Claims such as “94% reach their goal weight” or “lose weight twice as fast” are marketing statements, not trial results.

Here are the companies on one widely circulated list and what each advertises. The links go straight to each company’s own site, not through an advertiser. I am not recommending or ranking any of them.

• TrimRx: advertises tirzepatide and semaglutide without naming a brand. Its site lists care from $179 a month.

• altRx: advertises Zepbound, Wegovy, Ozempic, and semaglutide, from $89 a month.

• Shed: offers Zepbound and compounded tirzepatide, along with Wegovy, Ozempic, and semaglutide.

• Embody: advertises compounded semaglutide at $69 a month and compounded tirzepatide at $119 a month, plus brand-name options.

• Found: prescribes Zepbound, Wegovy, Foundayo, and compounded versions. Accepts many insurance plans and works with Medicare Part D members.

• Noom Med: prescribes Zepbound, Wegovy, Ozempic, and Mounjaro. Advertised from $79 a month.

• LevelsRx: offers compounded semaglutide and tirzepatide, advertised from $88 a month.

Three things to understand about this list:

• Price tells you what the product is. Genuine Zepbound costs $299 or more a month without insurance. “Tirzepatide” offered at $89 or $119 is a compounded product, not Zepbound. A low headline price may also be a membership fee with the medicine billed separately.

• The FDA is watching this industry closely. It sent warning letters to 30 telehealth companies in March 2026 and 25 more in June 2026 over misleading claims about compounded GLP-1 drugs. One company on this list, altRx, received a June 2026 warning letter. The FDA said its site implied altRx made the compounded drugs and described them as “clinically proven.”

• Check any company yourself. Search its name in the FDA warning letter database before you give it a credit card. A letter is a formal notice, not proof of harm, but it tells you how carefully a company speaks to patients.

Several of these companies do prescribe the genuine brand-name medicines. If you use one, choose that option, and tell them plainly: “I want FDA-approved Zepbound, not a compounded version.”

Ten questions for any online provider

A trustworthy service answers all ten without hesitation. Write the answers down.

1. Is this FDA-approved Zepbound, or a compounded product?

2. Which pharmacy fills it, and in which state is that pharmacy licensed?

3. Who is the prescriber, and are they licensed in my state?

4. Will a clinician review my full medication list and medical history before prescribing?

5. Do you order baseline labs, or accept recent ones from my doctor?

6. Can I reach a licensed clinician after I start, and how fast?

7. What is the total monthly cost at my maintenance dose, not just the starting dose?

8. How does the medicine ship, and what do I do if it arrives warm?

9. What is the cancellation and refund policy?

10. Will you send a record of my treatment to my own doctor?

Red flags

Walk away if a company does any of these. Most come straight from the FDA’s own warning list.

• Says its compounded drug is “the same as” or a “generic” of Zepbound or Mounjaro

• Offers prices that seem too good to be true

• Requires no real screening or prescription from a licensed clinician

• Has no licensed clinician you can reach after the medicine arrives

• Ships a product with spelling errors on the label, no instructions, damaged packaging, or a pharmacy name you cannot verify

• Sells retatrutide, cagrilintide, or anything labeled “for research use only.” These are not approved for anyone and cannot legally be compounded

• Suggests doses, schedules, or “microdosing” outside the approved label without a clear medical reason

• Sells through social media, a med spa back room, or an overseas website

Quick links and phone numbers

• Check your Zepbound coverage: zepbound.lilly.com/insurance-check

• Zepbound savings card: zepbound.lilly.com/savings, 1-866-923-1953

• Buy Zepbound direct (LillyDirect): lilly.com/lillydirect/medicines/zepbound

• Medicare weight-loss drug coverage: medicare.gov/coverage/weight-loss-drugs, 1-800-633-4227

• Wegovy self-pay (NovoCare Pharmacy): novocare.com

• Buying medicine online safely (FDA BeSafeRx): fda.gov BeSafeRx

• Look up a company’s FDA warning letters: FDA warning letter database

• Report a side effect or bad product (FDA MedWatch): fda.gov/medwatch

• FDA drug information line: 855-543-3784

What tirzepatide is

Tirzepatide is a once-weekly injection that mimics two gut hormones, GIP and GLP-1. It quiets appetite, slows stomach emptying, and improves how the body handles sugar.

It is sold under two brand names, both made by Eli Lilly. Zepbound is approved for weight management in adults with obesity, or overweight with a weight-related condition, and for moderate-to-severe obstructive sleep apnea with obesity. Mounjaro is approved for type 2 diabetes. There is no FDA-approved generic.

In the main obesity trial, people lost on average about 15% to 21% of their body weight over 72 weeks, depending on dose, alongside diet and activity changes. As a cardiologist I care about what comes with that: lower blood pressure, better blood sugar, less sleep apnea, and fewer heart failure events in people with obesity and a stiff heart.

Three things the advertisements leave out:

• It works while you take it. In trials, most people regained much of the weight within a year of stopping. Plan for long-term treatment, not a 90-day fix.

• Some of the weight you lose is muscle. Protein at every meal and resistance exercise twice a week protect it. This matters most after age 60.

• The dose is built up slowly. Treatment starts at 2.5 mg weekly and rises by 2.5 mg no faster than every four weeks, to a maintenance dose of 5, 10, or 15 mg. Rushing causes most of the misery people report.

Who needs a doctor’s review before starting

Some people should not take tirzepatide at all, and others need closer monitoring than an online form can provide.

Do not take it if you have:

• A personal or family history of medullary thyroid cancer, or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

• Had a serious allergic reaction to tirzepatide

• A pregnancy, or plans for one soon

See a physician in person first if you have or take:

• Past pancreatitis or gallbladder disease

• Gastroparesis or other serious stomach or bowel disease

• Diabetes treated with insulin or a sulfonylurea such as glipizide or glimepiride, because blood sugar can fall too low

• Diabetic eye disease

• Kidney disease, since vomiting and dehydration can injure the kidneys

• Blood pressure medicines, diuretics, or heart failure medicines, which often need lowering as weight comes off

• Warfarin or other medicines where small changes in absorption matter

• Birth control pills. Tirzepatide can make them less reliable. Use a backup method for four weeks after starting and after each dose increase

• A history of an eating disorder, or depression

• A surgery or procedure with anesthesia coming up. Tell the surgeon and the anesthesiologist

If any of these apply and an online service approves you in five minutes without asking about them, that tells you about the service.

Taking it safely, wherever you get it

Before the first dose

• Get a baseline: weight, blood pressure, heart rate, and basic labs including kidney function and blood sugar.

• Give the prescriber every medicine and supplement you take.

• Confirm your dose in milligrams, in writing. With vials, have someone show you exactly how much to draw up. The FDA has received reports of dosing mistakes with compounded GLP-1 vials that put people in the hospital.

Every week

• Inject once a week, on the same day. If you miss a dose, take it within four days. After that, skip it and resume on your usual day.

• Keep it refrigerated. Do not use any injection that arrives warm or without adequate cold packs.

• Use a new needle every time, and never share a pen or vial.

• If you use a multi-dose compounded vial, discard it 28 days after the first use, even if medicine remains.

• Eat protein at each meal, drink water through the day, and keep up strength exercise.

Expect and manage

Nausea, constipation, diarrhea, reflux, and fatigue are common, mostly after a dose increase. Smaller meals, less fat and alcohol, and slower eating help. If side effects are hard, staying longer at the current dose is reasonable. Ask before moving up.

Call your doctor the same day for

• Vomiting or diarrhea that keeps you from holding down fluids

• Lightheadedness, fainting, or home blood pressure readings running low

• Shakiness, sweating, or confusion if you take diabetes medicine

• A lump in the neck, hoarseness, or trouble swallowing

• Changes in vision, or a marked change in mood

Go to an emergency room for

• Severe, persistent upper abdominal pain, especially if it spreads to the back

• Pain under the right ribs with fever or yellowing of the skin or eyes

• Swelling of the face, lips, or throat, or trouble breathing

• Chest pain, or a racing or irregular heartbeat that does not settle

Report a bad reaction or a suspect product to the FDA’s MedWatch program.

Bring it back to your doctor

However you obtain tirzepatide, your own physician should know. Bring the product name, the dose, the pharmacy that filled it, and your weight and blood pressure log to your next visit. If you have no physician, make finding one part of this plan. The medicine works best as one piece of your care, alongside sleep, food, movement, and the people who know you.

Your body is entrusted to you. Treat the decision with the same care you would give any gift you intend to keep.

Blessings,

Afshine Ash Emrani, M.D., F.A.C.C.
Assistant Clinical Professor, UCLA David Geffen School of Medicine
Los Angeles Heart Specialists · 18370 Burbank Blvd., Suite 401, Tarzana, CA 91356 · 818-996-4100

If this guide helped you, stay with me. I write every week about living longer and living wiser.

• Subscribe to my Substack: substack.com/@afshineemrani

• Follow me on X: @afshineemrani

• Visit my website: doctoremrani.com

And please share this with one person who is struggling to afford this medicine. It may save them money, and it may keep them safe.

This guide is general education, not personal medical advice, and does not create a physician-patient relationship. Do not start, stop, or change any medication without speaking to your own doctor. Prices, programs, and regulations change often; confirm them before you act. Brand names belong to their owners. Company listings describe public advertising and are not endorsements.

Sources

• FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, current as of October 1, 2026

• FDA, Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s, March 3, 2026

• FDA, Warning letter to Trinity HealthCare Supply, LLC dba altRx, June 8, 2026

• Bloomberg Law, FDA Warns Companies Over Misleading Claims of GLP-1 Copycats, June 16, 2026

• Eli Lilly, Zepbound savings and self-pay terms, September 2026

• NPR and KFF Health News, Some Medicare beneficiaries can now get popular obesity drugs for $50 a month

• UnitedHealthcare provider notice, Medicare GLP-1 Bridge program: what you need to know, August 11, 2026

• Reuters via Benefits and Pensions Monitor, New lower-priced rival GLP-1 pill wins FDA approval, April 2026

• Novo Nordisk, NovoCare: price your Wegovy, checked October 11, 2026

• Each telehealth company’s own website, checked October 11, 2026